The QualityStocks Daily Thursday, January 23rd, 2020

Today's Top 3 Investment Newsletters

StockMarketWatch (TWMC) +66.67%

PennyStockScholar (CODX) +79.65%

QualityStocks (INND) +50.00%

The QualityStocks Daily Stock List

Driven Deliveries, Inc. (DRVD)

OTC Markets, Stock Price, Financial News Media, TipRanks, Investor Ideas, BioPortfolio, InvestorsHub, Investing.com, Cannabis Business Times, Stockopedia, Morningstar, GuruFocus, YCharts, Stockwatch, last10k, Seeking Alpha, Wallet Investor, TradingView, Dividend Investor, Simply Wall St, Stockhouse, and Barchart reported beforehand on Driven Deliveries, Inc. (DRVD), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Driven Deliveries, Inc. is the State of California's fastest growing online cannabis retailer and direct-to-consumer delivery company. It is the first U.S. based publicly traded cannabis delivery service operating within the USA. The Company previously went by the name Results-Based Outsourcing, Inc. It changed its name to Driven Deliveries, Inc. in September of 2018. Ganjarunner is a subsidiary of Driven Deliveries. Established in 2013, Driven Deliveries is headquartered in San Diego, California.

Driven Deliveries provides e-commerce solutions, online sales, as well as on-demand cannabis delivery in select cities where allowed by law. The Company offers legal cannabis consumers the ability to purchase and receive their marijuana in a quick and convenient way. Driven Deliveries offers a proprietary, turnkey delivery system to its customers.

The Company works with brands and their products to be the all-in-one delivery solution to California, Nevada, and Oregon. It enables brands to sell and deliver their products directly to consumers via e-commerce and home delivery solutions.

Driven Deliveries connects upstream cultivators, manufacturers, brands and retailers through software and logistics solutions. The Company covers 92 percent of California's population for next day and close to 60 percent same day. Driven delivers to urban, rural, and metropolitan areas and homes, businesses and hotels.

Last month, Driven Deliveries announced that it reached agreements with more than 25 brands to participate in its Fulfilled By Ganjarunner (FBG) brand-to-consumer offering. Driven signed deals with some of the most renowned brands in cannabis. These include Cresco Labs, Inc. (OTC: CRLBF), Sunderstorm, Uptown Canna Co., and Madrone. To further the partnership, Ganjarunner announced in December an agreement with Cresco Labs to deliver Cresco branded products. These include Cresco, Mindy's, Remedi, High Supply, and Good News.

Last week, Driven Deliveries announced considerable milestones realized in Q4. Through the quarter, Driven performed over 31,680 deliveries, acquired 2,587 new customers, and reduced the average new customer acquisition cost to $13.80 versus $22.16 in Q3. Moreover, Driven was able to increase the aggregate gross margin from retail sales by 3 percent, reduce its average delivery expense by 6 percent via integration of its three delivery operations, and increase product selection on dynamic menus by 160 percent.

Driven Deliveries, Inc. (DRVD), closed Thursday's trading session at $1.156, off by 0.344828%, on 9,740 volume with 24 trades. The average volume for the last 3 months is 49,610 and the stock's 52-week low/high is $0.349999994/$5.8499999.

Evergold Corp. (EVGUF)

PredictWallStreet, Morningstar, OTC Markets, Nasdaq, GuruFocus, Wallet Investor, InvestorsHub and Stockhouse reported previously on Evergold Corp. (EVGUF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Evergold Corp. engages in the exploration and development of mineral properties in the Province of British Columbia (B.C.). The Company has been assembled by a team with a record of recent success in British Columbia, combining four 100 percent-owned properties in prime geological real estate from one of B.C.’s best-known geologists, C.J. Greig, with experienced management and a highly qualified Board of Directors. Evergold lists on the OTC Markets. The Company has its corporate office in Toronto, Ontario.

Evergold’s projects include Snoball, Golden Lion, Holy Cross, and Spanish Lake. Snoball is 100 percent owned, has helicopter access, and is a 3,545-hectare property. It is drill-ready and offers near-term discovery potential. Golden Lion is 100 percent owned and also has helicopter access. It is a 5,099-hectare property and it is also drill-ready and also offers near-term discovery potential.

Spanish Lake is 100 percent owned and has drive-on road access. It is a 1,573-hectare property that offers near-term discovery potential. Moreover, Holy Cross is 100 percent owned and has direct road access. It is an 1,872-hectare property and is drill-ready and also offers near-term discovery potential.

Evergold is well financed with a $3.45 million IPO (Initial Public Offering) in October of 2019. Snoball and Golden Lion are the Company’s flagship properties. Its pipeline properties are Holy Cross and Spanish Lake. The target type at Snoball is high grade vein-hosted gold-silver, replacement/skarn, and intrusion-related bulk tonnage. Regarding Snoball, Evergold believes it has found the source of a large, strong, gold-silver anomaly, up-slope of previous work. It intends to drill it this year.

The target type at Golden Lion is high grade, vein-hosted epithermal gold-silver, coppergold-silver replacement/skarn, and bulk tonnage copper-gold porphyry. The target type at Holy Cross is high grade and/or bulk-tonnage intrusion-related gold+/-silver+/-copper. The target type at Spanish Lake is high grade and bulk tonnage sediment-hosted vein gold.

Evergold Corp. (EVGUF), closed Thursday's trading session at $0.25475, up 1.6966%, on 500 volume with 1 trade. The average volume for the last 3 months is 860 and the stock's 52-week low/high is $0.151999995/$0.254750013.

InnerScope Hearing Technologies, Inc. (INND)

NetworkNewsWire, Spotlight Growth, Street Insider, Stock Day Media, Insider Financial, Morningstar, Simply Wall St, OTC Markets, Stockopedia, GuruFocus, TradingView, TipRanks, InvestorsHub, PR Newswire, Seeking Alpha, Stockwatch, Stockhouse, Central Charts, and YCharts reported earlier on InnerScope Hearing Technologies, Inc. (INND), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, InnerScope Hearing Technologies, Inc. is a consolidator of the hearing aid industry. The Company’s direct-to-consumer model is transforming the industry with its Walmart.com, Sears.com, and Kmart.com relationship representing a paramount shift in the consumption of hearing aids by the hearing impaired. The Company previously went by the name Innerscope Advertising Agency, Inc. It changed its name to InnerScope Hearing Technologies, Inc. in August of 2017. Incorporated in 2012, the Company is based in Roseville, California.

Fundamentally, InnerScope Hearing Technologies is a manufacturer and Direct-to-Consumer (DTC) distributor/retailer of FDA-Registered Hearing Aids, Personal Sound Amplifiers Products, (Hearing Products) Hearing Related Treatment Therapies, Doctor-Formulated Dietary Hearing Supplements and proprietary CBD Oil (Hearing Health Products) (collectively its Hearing Product Portfolio).

InnerScope Hearing Technologies also plans to continue to open, acquire, and operate a physical chain of audiological and retail hearing aid clinics. The Company's mission is to serve roughly 1.2 billion people worldwide that are suffering with 25db or greater hearing loss across the entire hearing impaired vertical from research and development (R&D) and manufacturing through direct consumer sales and services.

Innerscope also has expertise and is a leader in the distribution of Direct-to-Consumer hearing products via big box retailers. The Company is a technology driven enterprise with highly scalable B2B and B2C solutions. Innerscope offers a B2B SaaS based Patient Management System (PMS) software program. In addition to improving operations and communication with patients, the Company will also provide a Buying Group experience for the audiology practice. This enables owners to reduce product costs and increase their margins.

Earlier this month, InnerScope Hearing Technologies announced its plans to distribute its new unattended fully automated shelf-top design of its Point of Sale Hearing Screening Retail Kiosks to major Big Box retailers and pharmacy chains. The Company specifically developed the Retail Shelf-Top Hearing Kiosk to be easily integrated alongside its Hearing Product Portfolio within any retailer's product shelf space or used as an end cap retail shelf display.

Yesterday, InnerScope Hearing Technologies announced the launch on Walmart.com of HearingVite™. Its HearingVite™ is a Doctor-Formulated dietary hearing supplement plus multi-vitamin for maintaining proper hearing health. HearingVite™ was purposely designed to provide "Nutrition for the Ears" to help people with hearing problems and to help avoid future hearing issues.

InnerScope Hearing Technologies, Inc. (INND), closed Thursday's trading session at $0.0012, up 50.00%, on 18,127,109 volume with 95 trades. The average volume for the last 3 months is 7,529,799 and the stock's 52-week low/high is $0.0006/$0.104999996.

Lixte Biotechnology Holdings, Inc. (LIXT)

BioPortfolio, OTC Markets, Research and Markets, Dividend Investor, Spotlight Growth, Wallet Investor, PR Newswire, GuruFocus, Emerging Growth, Simply Wall St, Last10k, Small Cap Network, Morningstar, Street Insider, Hotstocked, 4-Traders, InvestorsHub, Stockopedia, and Stockhouse reported beforehand on InterCure Ltd. (LIXT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Lixte Biotechnology Holdings, Inc. operates as a drug discovery company. It uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The Company’s product pipeline is chiefly focused on inhibitors of protein phosphatases, used alone and in combination with cytotoxic agents and/or X-ray and immune checkpoint blockers. A clinical-stage pharmaceutical enterprise, Lixte Biotechnology Holdings is based in East Setauket, New York.

The Company has identified molecular signaling pathways altered in disease states. In addition, Lixte has designed compounds that can safely target them in animal models. The Company’s current drug portfolio includes inhibitors of serine/threonine protein phosphatases vital to cell division and DNA damage repair and inhibitors of protein deacetylases, which regulate pathways of gene expression and protein degradation.

The phosphatase inhibitors enhance the effectiveness of cytotoxic anti-cancer drugs in general and radiation therapy. This makes them potentially useful for the treatment of many cancers in combination with existing standard chemotherapy regimens and with the developing targeted cytotoxic therapies of personalized cancer medicine.

Also, in a pre-clinical study done with scientists under collaborative research and development (R&D) agreements at the National Institutes of Health, Lixte Biotechnology’s lead compound, LB-100, enhanced the antitumor activity of a major immune checkpoint inhibitor. As a result, this raises the possibility that in addition to improving the efficacy of standard cytotoxic anti-cancer drugs, the Company’s phosphatase inhibitors may potentiate immunotherapy regimens (Ho 2017).

Last month, Lixte Biotechnology announced that the National Cancer Institute (NCI) enrolled the first two patients of a planned eight patient pharmacologic study of the ability of its lead compound, LB-100, to enter the brain and penetrate recurrent brain tumors in patients where surgical removal of the cancers is indicated (clinical trials registry NCT03027388). The study is being conducted by NCI under a Cooperative Research and Development Agreement (CRADA) with Lixte Biotechnology. The design of the NCI study is to ascertain the extent to which LB-100 enters recurrent malignant gliomas.

Lixte Biotechnology Holdings, Inc. (LIXT), closed Thursday's trading session at $0.70, even for the day, on 8,400 volume. The average volume for the last 3 months is 4,066 and the stock's 52-week low/high is $0.564999997/$1.45000004.

Town Center Bank (TCNB)

Penny Stock Hub, Speculating Stocks, OTC Markets, InvestorPoint, Financial Content, Morningstar, Dividend Investor, Whale Wisdom, Investors Hangout, Wallet Investor, Seeking Alpha, Stockhouse, Barchart, GuruFocus, Trading View, and YCharts reported earlier on Town Center Bank (TCNB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Town Center Bank (IL) provides diverse financial services to individuals and businesses in the State of Illinois. The Company operates through its offices in Frankfort and New Lenox, Illinois. Town Center Bank combines premier online/mobile banking, remote and Xpress deposit and bill payment with personal community bank service. Established in 2006, Town Center Bank is headquartered in New Lenox. The Company’s shares trade on the OTC Markets Group’s OTCQX.

Town Center Bank offers a range of deposit products. These include checking, savings, cash management, as well as term certificate accounts. It also offers varied lending products. These consist of residential mortgage, commercial, commercial real estate, construction, land development, and consumer loans.

The Company also offers home equity lines of credit, home equity loans, installment loans, working capital loans, secured or unsecured lines of credit, equipment loans, and asset and AR based loans. In addition, Town Center Bank provides online banking/bill payment, remote deposit capture, and Xpress deposit services. Furthermore, the Company offers debit and credit cards; and additional services, including coin counting and property tax payment services.

For businesses, Town Center Bank provides a broad range of customized, time-saving cash management services to meet the specific needs of a business. Online banking and bill pay are streamlined with the Company’s state-of-the-art electronic services.

For Business Banking, Town Center Bank offers Online Banking/Bill Payment; Remote/Xpress (Mobile) Deposit Capture; ACH Originations; Wire Originations; Check/ACH Positive Pay; and Zero Balance Accounts. Additionally, it offers Sweep Accounts, Merchant Card Processing Services; as well as Night Depository.

For Personal Banking, Town Center Bank has services available by way of online and mobile banking, such as checking balances, viewing account activity, transferring funds between checking and savings, and scheduling automatic payments. Services also include unique payments (entering a new amount and payment date whenever one needs), recurring payments, and also custom reports.

Town Center Bank (TCNB), closed Thursday's trading session at $3.45, even for the day, on 1,900 volume. The average volume for the last 3 months is 659 and the stock's 52-week low/high is $6.21999979/$13.7200002.

Vitalibis, Inc. (VCBD)

StockFlare, Invest Tribune, Stockhouse, InvestorsHub, Stockwatch, Wallmine, biotech capital, Trading View, Investors Hangout, Investors News, Teletrader, Dividend Investor, 4-Traders, Market Screener, GlobeNewswire, Real Investment Advice, Simply Wall St, Wallet Investor, and Market Exclusive reported previously on Vitalibis, Inc. (VCBD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Vitalibis, Inc. is a technology based formulator of premium hemp-based cannabidiol (CBD) wellness products. It is also a formulator of safe personal care and nutritional products. Its sales model maximizes a one-brand, multi-channel framework. The Company was previously known as Sheng Ying Entertainment Corp. It changed its name to Vitalibis, Inc. in February of 2018. Vitalibis has its head office in Las Vegas, Nevada.

Vitalibis offers its full spectrum, phyto-cannabinoid rich hemp oil. The Company sources premium, organically grown industrial hemp from Colorado. It utilizes a patent-pending extraction process that uses precise bursts of heat in comparison to harmful solvents or CO2. All of its products are validated by independent third-party testing labs.

Regarding Personal Care products, Vitalibis’ screening process eliminates more than 1,400 ingredients before formulation starts. Furthermore, the Company employs cold processing techniques to retain more of its ingredient benefits. In addition, its nutritional products are certified organic and formulated specifically for optimal results. Vitalibis has partnered with the best leaders in quantum neurology and holistic health to create these products.

In December, Vitalibis announced that it recently entered into a national alliance with OakLeaf Wellness + Health, promoting and distributing the Vitalibis brand of high-quality CBD oils and creams to wellness professionals around the country. Starting with its flagship, Tolk Chiropractic and Wellness Center, OakLeaf is facilitating all facets of the distribution process, from developing digital marketing assets to providing attractive counter-top displays and training.

Dr. David Tolk, Medical Director of OakLeaf Wellness + Health, said, “When it comes to CBD brands, Vitalibis is the cream of the crop. I have so much respect for their company values as well as the level of care they put into all of their products. Every level of their sourcing process is done the right way, for both our patients and the planet. Best of all, they are one of the few CBD companies that I have seen to offer limited liability insurance, protecting both the patient and practitioners.”

Earlier this month, Vitalibis announced that it recently entered into a business alliance with Less Leg More Heart (LLMH). The relationship will help support LLMH’s mission to spread hope, lessen suffering and to enhance physical/mental viability through providing customized services/supplies to patients and their families during life changing medical circumstances. As Customers shop and purchase Vitalibis products using this unique URL (https://www.vitalibis.com/llmh), assigned solely and exclusively for LLMH, Vitalibis will allocate 20 percent of the purchase price from each product sale to LLMH’s general fund.

Vitalibis, Inc. (VCBD), closed Thursday's trading session at $0.23, even for the day, on 39 volume with 1 trade. The average volume for the last 3 months is 27,025 and the stock's 52-week low/high is $0.093999996/$3.53999996.

Williams Industrial Services Group, Inc. (WLMS)

NetworkNewsWire, Zacks, TipRanks, TMXmoney, Seeking Alpha, Whale Wisdom, OTC Markets, Market Wire News, MarketBeat, last10k, Simply Wall St, GuruFocus, Nasdaq, PR Newswire, TradingView, MarketWatch, Stockopedia, Morningstar, Proactive Investors, and Financial Buzz reported beforehand on Williams Industrial Services Group, Inc. (WLMS), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Williams Industrial Services Group, Inc. is a construction and maintenance services company headquartered in Tucker, Georgia. It provides a broad range of construction, maintenance and modification, and support services to customers in energy, power and industrial end markets. The Company formerly went by the name Global Power Equipment Group, Inc. It changed its corporate name to Williams Industrial Services Group, Inc. in June of 2018. Established in 1958, the Company lists on the OTC Markets’ OTCQX.

Williams Industrial Services Group provides Plant Services, Specialty Services, as well as Industrial Services. Concerning Plant Services, it is a leading provider of complete plant maintenance and modifications services, capital construction, and a wide variety of specialty and support services to its clients in the power generation, oil and gas, pulp and paper, and other heavy industrial markets. Services include support for ongoing plant operations, regularly scheduled and emergency outages, refueling, shutdowns, turnarounds, and other major maintenance projects required by its clients.

Williams Industrial Services Group is a multi-industry leader in Specialty Services. It has set the standard for protective coatings application, insulation, roofing systems, asbestos and lead abatement and other maintenance specialties in an assortment of industrial markets.

Regarding Industrial Services, the Company provides almost all of the services provided by its Plant and Specialty Services companies - but in open shop labor environments. Work typically performed includes Facility Maintenance, Major Modifications, Outages, Shutdowns and Turnarounds, and New Construction. Main industries served include Water & Wastewater Treatment, Oil & Gas/Petrochemical, Pulp & Paper, and Power Generation.

Last week, Williams Industrial Services Group announced that its subsidiary, WISG Canada, Ltd. (Williams Canada), was awarded a one-year, C$40 million contract to manage project controls for Bruce Power in the Province of Ontario. The project is included in 2019 total backlog.

Williams Canada will provide turnkey project controls services to Bruce Power. This will ensure accurate internal reporting for Bruce Power’s most important programs and projects, including roughly C$13 billion in capital investments for the refurbishments and upgrades to extend the life of six nuclear reactors. Bruce Power produces 30 percent of Ontario’s electricity at 30 percent less than the average cost to generate residential power.

Williams Industrial Services Group, Inc. (WLMS), closed Thursday's trading session at $1.60, up 5.2632%, on 45,573 volume with 98 trades. The average volume for the last 3 months is 20,096 and the stock's 52-week low/high is $1.33000004/$2.49.

GT Biopharma, Inc. (GTBP)

NetworkNewsWire, Stockhouse, Infront Analytics, MarketWatch, The Street, Stockopedia, PR Newswire, GuruFocus, InvestorsHub, Insider Financial, Market Screener, OTC Markets, Morningstar, YCharts, Street Insider, and Simply Wall St reported previously on GT Biopharma, Inc. (GTBP), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

GT Biopharma, Inc. focuses on unique drugs for the treatment of cancer and CNS diseases (Neurology and Pain), along with other unmet medical needs. The Company’s lead oncology drug candidate is OXS-1550 (DT2219ARL). It owns the worldwide rights to commercialize OXS-1550. GT Biopharma is based in Tampa, Florida and the Company lists on the OTC Markets’ OTCQB.

GT Biopharma concentrates on innovative treatments based on its proprietary NK-engager and Bispecific Antibody Drug Conjugate platforms. The Company is targeting multiple myeloma, triple-negative breast cancer, non-Hodgkin’s lymphoma, and more. It is doing so with highly potent biopharmaceutical drugs designed for targeted therapy. Its current CNS pipeline products include treatment for neuropathic pain, the symptoms of myasthenia gravis, and motion sickness.

GT Biopharma’s CNS platform focuses on acquiring or discovering and patenting late-stage, de-risked, and close-to-market improved treatments for CNS diseases. Furthermore, the CNS platform focuses on guiding the products through the Food and Drug Administration (FDA) approval process to the NDA.

OXS-1550 is an ADC (Antibody Drug Conjugate) drug. What makes OXS-1550 (DT2219ARL) different from other treatments, such as chemotherapy, is that the design of it is to specifically target and kill cancer cells while reducing damage to normal tissues. OXS-1550 has demonstrated success in early human clinical trials in patients with relapsed/refractory B-cell lymphoma or leukemia. When OXS-1550 binds to cancer cells, the cancer cells internalize the drug and are killed due to the action of cytotoxic payload. 

Researchers at the University of Minnesota Masonic Cancer Center developed the OXS-3550 TriKE technology. This targeted immunotherapy directs immune cells to kill cancer cells while decreasing drug-related toxicity.

Recently, GT Biopharma announced that it presented data demonstrating the effectiveness of its Tri-specific Killer Engagers (TriKEs) for the treatment of acute myeloid leukemia (AML) presented at the American Society of Hematology (ASH) Annual Meeting.

Raymond Urbanski, M.D., Ph.D., Chief Executive Officer of GT Biopharma, said, “We continue to be encouraged by the data from our Trike program being conducted by leading NK cell experts at the University of Minnesota. These findings have supported us with the confidence to proceed with our first-in-class TriKE, Phase 1 study.”

GT Biopharma, Inc. (GTBP), closed Thursday's trading session at $0.1099, up 21.4365%, on 65,401 volume with 41 trades. The average volume for the last 3 months is 127,148 and the stock's 52-week low/high is $0.064999997/$0.75.

CurAegis Technologies, Inc. (CRGS)

Penny Stock Tweets, Dividend Investor, Insider Mole, Equity Clock, Market Screener, Morningstar, MarketWatch, 4-Traders, InvestorsHub, Stockwatch, Investor Place, Simply Wall St, Marketbeat, Capital Cube, YCharts, Stock Invest, Barchart, The Street, OTC Markets, Infront Analytics, Stockhouse, last10k, Wallet Investor, and TradingView reported earlier on CurAegis Technologies, Inc. (CRGS), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter. 

CurAegis Technologies, Inc. develops and markets advanced technologies in the areas of power, safety, and wellness. The Company consists of two independent divisions. One is its CURA Division and the other is its Aegis Division.  CurAegis is now concentrating on commercialization strategies in diverse technologies. These include the CURA system, which includes the myCadian™ watch that measures degradation of alertness and sleep attributes; the Z-Coach e-learning education and training tool, and the Aegis hydraulic pump. OTCQB-listed, CurAegis Technologies is based in Rochester, New York.

The CURA™ system and the myCadian™ watch enable the user and third parties to anticipate and prevent undesired or disastrous situations caused by the degradation of alertness. CurAegis completed its validation studies of the CURA System at the University of Colorado at Boulder and the University of Rochester Medical Center. The Company previously said that it can now state that it can predict a person’s fatigue level, at close to laboratory accuracy, in real-time.

The CURA System consists of hardware and software, which measures numerous metrics to establish that a person's ability to perform a task or job appears to be degrading. The CURA division is developing a proprietary technology and family of products designed to measure the reduction in a person’s alertness and to train persons on how to improve alertness levels. The CURA System gives a person accurate and relevant real-time information regarding their current and long-term sleep and fatigue health.

The Company’s Aegis hydraulic pump (Aegis Division) is an innovative hydraulic design. Its goal is to deliver better efficiencies in a package that is smaller and lighter than contemporary technologies.  Moreover, in 2015, the Z-Coach e-learning tool was acquired by CurAegis Technologies. The Z-Coach® Wellness Program is a robust, proven and proprietary online sleep training and education solution to address sleep issues and improve wellness.

In December, Mr. Richard A. Kaplan, Chief Executive Officer of CurAegis Technologies announced that Mr. Lance F. Drummond was appointed to the Company’s Board of Directors. At present, Mr. Drummond is a Board member of Federal Home Loan Mortgage Corporation (Freddie Mac). He has served on the Audit Committee and Nominations and Governance Committee since 2015. He is a Board member for United Community Bank, Inc. since 2018, where he serves on the Risk Committee, Nominating and Governance Committee and Compensation Committee.

CurAegis Technologies, Inc. (CRGS), closed Thursday's trading session at $0.11, up 22.2222%, on 24,500 volume with 1 trade. The average volume for the last 3 months is 39,404 and the stock's 52-week low/high is $0.005599999/$0.300000011.

International Stem Cell Corp. (ISCO)

Tip.us, MissionIR, Serious Traders, Tiny Gems, Market Screener, StockInvest, Marketbeat, GuruFocus, Equity Clock, Research Gate, Canadian Insider, StocksToBuyNow, Zacks and Morningstar reported earlier on International Stem Cell Corp. (ISCO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

International Stem Cell Corp. is a clinical stage biotechnology company headquartered in Carlsbad, California. It is developing stem cell-based therapies and biomedical products. The Company’s focus is on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. International Stem Cell has a research facility in Oceanside, California.

The Company’s core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). The hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. They offer the potential to create the first true stem cell bank, UniStemCell™.

The UniStemCell™ bank is the life science industry’s first collection of non-embryonic histocompatible human stem cells available for research and commercial use. The human leukocyte antigen (HLA) system represents antigens vital for transplantation.

International Stem Cell scientists have created the first parthenogenetic, homozygous stem cell line. The Company produces and markets specialized cells and growth media for therapeutic research around the world through its subsidiary Lifeline Cell Technology and stem cell-based skin care products through its subsidiary Lifeline Skin Care.

This past November, International Stem Cell announced positive 12-month results of the first cohort and six-month interim results of the second cohort of its presently-ongoing, single-arm, open-label phase 1 clinical study (NCT02452723) evaluating the safety and tolerability of its lead candidate, ISC-hpNSC®, a cellular therapeutic comprising human parthenogenetic neural stem cells, for the treatment of Parkinson’s disease (PD).

Six of the 12 patients in the clinical trial completed one year of follow-up observations. One patient in the low dose cohort has now been followed for 2 years. There have been no safety signals or serious adverse effects seen to date as related to the transplanted ISC-hpNSC® cells.

The evaluation is based on greater than 12 months of safety data from the first cohort (low dose), and 6 months of data from the second cohort (mid dose). Each cohort consists of 4 patients. Dosing of patients in Cohort 3, which is receiving the highest dose, is ongoing.

International Stem Cell Corp. (ISCO), closed Thursday's trading session at $1.048, up 26.2651%, on 8,120 volume with 30 trades. The average volume for the last 3 months is 5,201 and the stock's 52-week low/high is $0.351200014/$1.60000002.

CareView Communications, Inc. (CRVW)

Tiny Gems, MissionIR, Stockopedia, Stock Invest, Monster Stocks Pick, FeedBlitz, Real Pennies, PennyTrader Publisher, Wall Street Resources, Wallet Investor, Plunkett Research, TradingView, BabyBulls, Pink Investing, Stock Stars, and Capital Cube reported previously on CareView Communications, Inc. (CRVW), and today we report on the Company, here at the QualityStocks Daily Newsletter. 

CareView Communications, Inc. is an Information Technology (IT) provider to the healthcare industry. CareView provides the next generation of patient care through its cutting-edge data and patient monitoring system. This system connects patients, families and healthcare professionals (the CareView System®). The CareView System can help a hospital reduce sitter costs, patient falls and injuries, manage patient flow, improve internal communications, and consolidate vendors. OTCQB-listed, CareView Communications has its corporate headquarters in Lewisville, Texas.  

The CareView System is HIPAA (Health Insurance Portability and Accountability Act) -compliant and secure.  The System does not record anything. Additionally, it can include consent processes and privacy options. Pertaining to hospital benefits, the CareView System enables patients to watch first-run movies and access high-speed internet. The result of this is increased patient satisfaction.

CareView Communications’ proprietary, high-speed data network system may be installed throughout a healthcare facility to provide the facility with recurring revenue and infrastructure for future applications. The CareView System allows for close observation of high-risk patients from numerous locations. The CareView Connect® mobile application provides patient monitoring and critical communication tools from an existing Wi-Fi Android or iOS device. The CareView System employs an infrared camera in patient rooms to deliver real-time visual monitoring 24/7.

CareView Communications offers its CareView Connect Senior Care Quality of Life System™. This is a unique family of products and services, which improve the quality of life and safety of seniors who reside in independent and assisted living facilities, or who live alone at home. The CareView Connect Senior Care Quality of Life System™ consists of a small emergency assist button or pendant, passive motion sensors, bed sensors, and event sensors. The CareView Connect System passively monitors a resident's daily activities.

Recently, CareView Communications announced the execution of a three-year group purchasing agreement with Pandion Optimization Alliance. Pandion is a 70-year old not-for-profit group purchasing organization dedicated to member hospitals, non-acute health-care related facilities and related industries. Pandion GPO has thousands of members covering 50 states. Pandion GPO provides an assortment of supply chain services and solutions including group purchasing and supply chain consulting to help lessen costs, streamline operations and improve performance of its members.

CareView Communications, Inc. (CRVW), closed Thursday's trading session at $0.01, up 17.6471%, on 1,367,000 volume with 18 trades. The average volume for the last 3 months is 232,996 and the stock's 52-week low/high is $0.004199999/$0.026799999.

NanoFlex Power Corp. (OPVS)

Dividend Investor, Zacks, Wallet Investor, Stockhouse, MarketWatch, MicroCapResearch, InvestorsHub, Super Stock Screener, and Morningstar reported earlier on NanoFlex Power Corp. (OPVS), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

NanoFlex Power Corp. engages in the research, development, and commercialization of advanced configuration solar technologies. These technologies enable innovative thin-film solar cell implementations. The Company believes these will be industry-leading efficiencies, light weight, flexible, and low total system cost. Listed on the OTC Markets Group’s OTCQB, NanoFlex Power has its corporate office in Scottsdale, Arizona.

The Company’s sponsored research agreements provide it with the exclusive worldwide license and right to sublicense any and all Intellectual Property (IP)  resulting from the related research and development (R&D) efforts at different universities. NanoFlex Power entered into a license agreement with SolAero Technologies Corp. For the last two-plus years, the Company and SolAero have partnered to validate NanoFlex's patented, non-destructive epitaxial lift-off (ND-ELO) process and related technologies in SolAero's ultra-high efficiency solar cells.

SolAero is a global leader in high performance photovoltaics for space and terrestrial applications. SolAero is a leading manufacturer of high efficiency solar cells.

NanoFlex Power is part of a consortium that was awarded a $6.5 million contract from the Army Research Laboratory's Army Research Office.

This consortium comprises NanoFlex Power,  SolAero Technologies, the University of Michigan (UM), and the University of Wisconsin (UW).   The contract is to develop high power, flexible, and lightweight solar modules for portable power applications with more than double the power of existing flexible solar modules within the same footprint at a competitive procurement cost on a dollars per Watt basis.

Research programs have produced two solar thin film technology platforms. One is Gallium Arsenide (GaAs) thin film technology for high power applications. The other is organic photovoltaic (OPV) technology for applications requiring high quality aesthetics.

NanoFlex Power has the exclusive worldwide rights to license, sublicense, and bring its own products to market using the aforementioned  ND-ELO technology. ND-ELO technology has the potential to reduce compound semiconductor production costs by greater than 40 percent through enabling reuse of the expensive wafer substrate.

NanoFlex Power Corp. (OPVS), closed Thursday's trading session at $0.104, up 42.2709%, on 9,450 volume with 4 trades. The average volume for the last 3 months is 11,462 and the stock's 52-week low/high is $0.0412/$0.189999997.

MYM Nutraceuticals, Inc. (MYMMF)

Stockhouse, MarketWatch, OTC Markets, Barchart, Investing, InvestorsHub, and Market News Updates reported on MYM Nutraceuticals, Inc. (MYMMF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

MYM Nutraceuticals, Inc. focuses on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products. The Company is looking to acquire complementary businesses and assets in the technology, nutraceuticals, and CBD sectors. MYM is the sole owner of CBD brands HempMed, Joshua Tree, and Dr. Furbaby. MYM Nutraceuticals is based in Vancouver, British Columbia.

Dr. Furbaby is the Company’s CBD line of products specifically for pets. HempMed is targeted at the dispensary market. Joshua Tree is targeted for the mainstream health market.

Currently, MYM Nutraceuticals is constructing three large-scale production facilities in Canada and Australia. These are the Northern Rivers Project; the Weedon Project; and the Laval Project. Upon completion, the total amount of greenhouse growing space will be more than 2.7 million square feet.

The Laval Project facility (Laval, Quebec) is 10,000 sq. ft. It will undergo expansion to 26,000 sq. ft. by 2019. The estimation is that the Laval Project will generate sales of $20 million by 2019.

The Northern Rivers Project (Casino, New South Wales, Australia) is a 1.2 million sq. ft. greenhouse project. The expectation is that the first crop will be planted in Q4 2018. The Northern Rivers Project facility is believed to be the Southern Hemisphere's largest purpose-built greenhouse, designed specifically to produce medical-grade cannabis.

The Weedon Project is in Weedon, Quebec. This Project will include a cannabis museum and a cannabis university for industry training. The Weedon Project has 1.5 million sq. ft. of greenhouse. MYM received approval and started Phase One construction of the Weedon production facility.

Additionality, the Company has its MJT Manufacturing Project (Toronto, Ontario). The 5,000 sq. ft. production facility is a GMP (Good Manufacturing Practice) certified, state-of-the-art extraction lab and production facility dedicated to industrial hemp processing (CBD). MYM Nutraceuticals has acquired an additional 18 percent of CannaCanada and the Weedon, Quebec project bringing its total ownership of the late stage ACMPR applicant, up to 93 percent.

Recently, MYM Nutraceuticals announced that it entered into a partnership with the University of Sherbrooke to study the medicinal and industrial uses of cannabis and hemp. Researchers at the University of Sherbrooke will work with an on-site coordinator to establish partnerships through targeting expertise in different faculties and training centers.

Mr. Rob Gietl, MYM Nutraceuticals’ Chief Executive Officer, said, "The signing of this partnership agreement with University of Sherbrooke furthers our goal to be at the forefront of cannabis plant research and development. Furthermore, I am delighted to see our company associated with a large Quebec university that has an outstanding reputation in research and innovation."

MYM Nutraceuticals, Inc. (MYMMF), closed Thursday's trading session at $0.0697, up 20.1724%, on 359,682 volume with 44 trades. The average volume for the last 3 months is 188,187 and the stock's 52-week low/high is $0.05/$0.50999999.

Mymetics Corp. (MYMX)

TopPennyStockMovers, Market Intel Reports, and The Dean reported previously on Mymetics Corp. (MYMX), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Mymetics Corp. is a biotechnology company listed on the OTC Markets Group’s OTCQB. The Company is developing next-generation preventative vaccines for infectious diseases. Its vision is to become the market leader in the development of new generation mucosal and virosomes based vaccines. Mymetics has its corporate office in Epalinges, Switzerland.

Mymetics has a Research Lab in the Netherlands. The Company’s core technology and expertise are in the use of virosomes, lipid-based carriers containing functional fusion viral proteins and natural membrane proteins, in combination with rationally designed antigens. Currently, Mymetics has a group of vaccines in its pipeline: HIV-1/AIDS, intra-nasal Influenza, Malaria, Chikungunya, Herpes Simplex Virus, and the RSV vaccine.

The design of the Company’s vaccines is to induce protection against early transmission and infection, focusing on the mucosal immune response as a first-line defense, which for some pathogens may be critical for the development of an effective prophylactic vaccine. The HIV, malaria, and intra-nasal influenza vaccines have successfully completed Phase 1 clinical trials. The others are in the pre-clinical phase.

Mymetics is concentrating on developing pioneering preventative vaccines utilizing two key scientific approaches. One is Virosomes as an effective adjuvant and a vaccine delivery method. The other is unique antigen design through generating mucosal antibodies.

Through focusing on these two scientific approaches, Mymetics’ strategy is addressing two important needs in developing effective vaccines. One is the ability to build a first line of defense against viruses entering the blood stream through centering on the mucosal layer. The other is the development of a new vaccine delivery platform that doesn’t use live attenuated or killed pathogens, while increasing the immunogenicity and stability of the vaccine.

Mymetics’ subsidiary, Mymetics B.V., has agreed on a research project with Sanofi Pasteur, the vaccine division of Sanofi (SNY). The project will investigate the immunogenicity of influenza vaccines based on Mymetics' proprietary virosome technology platform in pre-clinical settings.

Mymetics has recently presented new preclinical data. The new data demonstrates that nasal powder, oral capsules, and sublingual tablets developed by MACIVIVA partners, containing Mymetics HIV-1 virosome based vaccine candidate, could induce specific antibody immune response in rodent and mini-pig animal models.

The results are generated under the MACIVIVA project (an EU Horizon 2020 project) that stands for "Manufacturing process for Cold-chain Independent Virosome-based Vaccines." The project began in May of 2015. It has a duration total of 3.5 years.

This project brings together top contract manufacturers and the relevant expertise for spray drying, freeze drying, and analytical techniques from the pharmaceutical industry. This is to develop a scalable manufacturing process to attain thermostable and cold-chain independent virosome based vaccines.

Mymetics Corp. (MYMX), closed Thursday's trading session at $0.0379, up 18.4375%, on 24,058 volume with 5 trades. The average volume for the last 3 months is 51,840 and the stock's 52-week low/high is $0.019999999/$0.059.

The QualityStocks Company Corner

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) was featured today in a publication from CBDWire, examining how, if you have you been paying attention to the news recently, you’ll undoubtedly have heard of cannabidiol or CBD. It’s a chemical extracted from the hemp plant, and going by the anecdotal evidence and some research findings, it’s a potent and versatile medicine. Users claim cannabidiol gave them relief from a plethora of conditions, ranging from high blood pressure and chronic pain to anxiety and insomnia.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Thursday's trading session at $1.11, up 0.909091%, on 35,036 volume with 89 trades. The average volume for the last 3 months is 50,708 and the stock's 52-week low/high is $0.839999973/$6.00810003.

Recent News

Nightfood Holdings, Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings, Inc. (NGTF).

Nightfood Holdings (OTCQB: NGTF), the award-winning ice cream company addressing America’s $50 billion-dollar nighttime snacking problem, today announced that its Founder and CEO Sean Folkson this week extended his existing lock-up agreement for an additional twelve-month period into 2021. To view the full press release, visit http://nnw.fm/xYKF7.

Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving late-night snacking for consumers and solving America’s $50 billion-dollar nighttime snacking problem.

Nightfood Ice Cream

Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in the ice cream category in a Kantar survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try.

Nightfood has secured distribution in several major regional supermarket chains and has landed media coverage in major outlets such as The Today Show, The Wall Street Journal, Oprah Magazine, USA Today, The Washington Post, Parents Magazine, and many more.

Over 80% of consumers snack regularly at night, and the most popular choices are cookies, chips, candy, and, of course, ice cream. These are understood to be both unhealthy and sleep-disruptive.

Research indicates that human biological programming combined with the trappings of modern life combine to drive this unhealthy behavior pattern. Every week, hundreds of millions of Americans combine to spend an estimated $1B on snacks consumed between dinner and bed.

In a recent Harris Poll online study, 54% of consumers who snack at night reported often feeling guilty about their nighttime snack choices. 58% said they wish they felt more in control of their nighttime snacking.

Nightfood management believes that the company that solves this massive consumer problem can become a national brand with a billion-dollar valuation.

Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.

Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.

MJ Munchies, Inc.

MJ Munchies, Inc. was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company is seeking licensing opportunities to market such products under the brand name “Half-Baked,” for which they’ve successfully secured trademark rights.

Management Team

Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.

Jim Christensen, vice president of Nightfood Ice Cream, is the former vice president of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Christensen led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.

CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small-cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.

Advisory Board

The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.

Nightfood Holdings, Inc. (NGTF), closed Thursday's trading session at $0.2195, up 4.5238%, on 126,424 volume with 48 trades. The average volume for the last 3 months is 108,993 and the stock's 52-week low/high is $0.187999993/$0.920000016.

Recent News

Xalles Holdings Inc. (OTC: XALL)

The QualityStocks Daily Newsletter would like to spotlight Xalles Holdings Inc. (OTC: XALL).

Xalles Holdings Inc. (OTC: XALL), one of the first providers of payment and financial transaction management solutions through proprietary blockchain-based technology, announced it has executed an agreement for the acquisition of Gateway Innovations Limited. This company, which is based in Accra, Ghana, is a major investor in Africa’s fintech and IT market, according to a Xalles Holdings press release (http://ccw.fm/c9CjD).

Xalles Holdings Inc. (OTC: XALL) is a fintech holding company leveraging blockchain and other technologies for e-commerce, payments, financial reconciliation, and payment auditing solutions. The company actively seeks acquisition targets with strong management teams and business models, large total attainable markets, and lucrative exit opportunities in which to invest and accelerate growth.

Operations

The common element to all acquired entities and projects is a business model that involves setting up a payment or financial transaction “toll gate,” thereby creating a recurring revenue stream.

Xalles’ business plan focuses on consumer, business and government-oriented payment and financial reconciliation transactions. Combining the blockchain decentralized financial ledger platform with the company’s existing X2X transaction reconciliation system design, Xalles is building technology that supports payment audits, exchanges, and new business models and opportunities worldwide. Xalles will launch new services card and mobile payment and rewards systems, and will expand the technology offerings for referral marketing and e-commerce engines.

Subsidiaries
(all current subsidiaries are wholly owned)

  • Xalles Holdings
    Raise capital for fintech accelerator program acquisitions, provide management, administrative, finance and marketing support to all subsidiary companies
  • Xalles Capital
    Management support of investment consortiums, direct investment into funds or projects, and management of investments
  • Xalles Limited
    Design and market new X2X solutions; acquire U.S Government transportation post-payment audit business through GSA schedule and expand to non-transportation payment auditing
  • Xalles Technology
    Technical development of the X2X blockchain systems
  • Xalles Financial Services
    Consumer and small business financial service offerings
  • Co-Owners Rewards
    Stock-based rewards system for payments cards and financial services
  • Amazing Living Enterprises
    Affiliate program and e-commerce platform for enhancing financial lives
  • Global Savings Network
    Not-for-profit fundraising system with consumer discounts at local merchants

X2X Solutions

Xalles provides payment and financial transaction management solutions through the company’s proprietary blockchain-based X2X technology. The X2X solution includes the Investment and Financing System (IFS), which supports complex investment structures, assists international investment consortia, and provides links to Xalles’ Financial Transaction Reconciliation (FTR) solution. FTR supports complex financial ecosystems, making it easier for parties to exchange products, services, grants and government incentives, and assists “Exchange Managers” with liquidity and auditability. X2X also supports the Xalles pre- and post-payment auditing services.

Plans for 2020

  • Xalles expects to announce new acquisitions of fintech growth firms.
  • The company’s strategy for 2020 includes revamping its consumer Commerce platform, to bring in the best elements of local and online shopping with payment tools and a unique rewards program.
  • Xalles Financial Services expects to expand its cryptocurrency related service offerings through partnerships, acquisitions and organic growth
  • The Blockchain based X2X system will continue to be enhanced to deliver new financial reconciliation services to large enterprises and governments.

Xalles Holdings Inc. (OTC: XALL), closed Thursday's trading session at $0.0019, up 11.7647%, on 1,201,876 volume with 11 trades. The average volume for the last 3 months is 1,744,376 and the stock's 52-week low/high is $0.0013/$0.021029999.

Recent News

Jerrick Media Holdings, Inc. (OTC: JMDA)

The QualityStocks Daily Newsletter would like to spotlight Jerrick Media Holdings, Inc. (OTC: JMDA).

Zacks Small-Cap Research has initiated coverage on Jerrick Media Holdings (OTCQB: JMDA), a holding company that gives technology products the resources and opportunities to make ideas a reality. Among other highlights, the research report provides an outlook and overview of the company, details regarding the industry and competition, a report of the company’s financials, and a valuation. To view the full press release, visit http://nnw.fm/y2gsU.

Jerrick Media Holdings, Inc. (OTC: JMDA) develops technology-based solutions to solve digital problems. Through the combination of design, thought and data analysis, the company builds products that influence a worldwide audience.

Jerrick’s flagship product is Vocal, a proprietary long-form digital publishing platform that provides storytelling tools and engaged communities for creators to get discovered and fund their creativity.

Vocal

Designed to develop and cost-effectively engage content creators, the Vocal platform enables its over 500,000 registered content creators to reach an engaged audience and monetize their content. In addition to providing relevant content, Vocal’s technology is centered on efficiency and scalability through its niche digital communities, as well as output through its data-driven distribution strategy.

Vocal partners with content creators and brands that recognize difficulties inherent in the digital advertising space and that can benefit from branded content marketing opportunities available on publishing platforms like Vocal.

All content available on Vocal is created within the platform’s custom editor and published on one of Vocal’s embedded genre-specific communities, spanning topics that range from food to wellness, beauty, technology and more.

In May 2019, Jerrick launched Vocal+, its premium subscription membership program. Vocal+ members pay a membership fee for premium value-added features, including receiving increased earnings for their content, reduced platform processing fees for tips received, a Vocal+ badge on their creator page, access to new features on the Vocal Platform, and other rewards. Creators can sign up for free or upgrade to Vocal+, available for purchase on either an annual or monthly subscription basis.

 

Vocal for Brands

Vocal for Brands is an in-house creative studio that generates actionable data from bespoke native advertising campaigns. Vocal for Brands partners with direct-to-consumer (DTC) to create beautiful, campaign-optimized stories on Vocal that build brand affinity, trust and drive results.

Additionally, Jerrick provides a Managed Services offering to business-to-business (B2B) and business-to-consumer (B2C) product and service brands which encompasses a full range of digital marketing and e-commerce solutions. Managed Services includes the setup and ongoing maintenance of clients’ websites, Amazon and Shopify storefronts and listings, social media pages, search engine marketing, and other various tools and sales channels utilized by e-commerce sellers for sales and growth optimization. In addition to partnering with Managed Services clients, the company offers a range of la carte services.

Growth Strategy

Upon the consummation of its anticipated listing on the Nasdaq Capital Market, Jerrick intends to change its official company name to “Creatd, Inc.,” subject to stockholder approval.

This rebranding will initiate Jerrick’s go-forward growth strategy and its plans to expand its offerings and provide technology products and resources for creators to help transform their ideas into reality. The strategic plan is designed to greatly increase Jerrick’s potential market value via a plethora of new revenue streams.

Creatd will focus on a community of creators that number more than 2.5 billion users, for which it will offer democratized, transparent platforms for distribution, sentiment, resources and monetization. The company’s agile development process will rely on a combination of bleeding-edge technology that eliminates barriers and creates efficiencies. Superior design thinking and data analysis will allow Creatd to expand its digital footprint to a global community.

Creatd will partner with a community of technology collaborators and sophisticated investors who collaborate to provide technology solutions for creators, brands and their respective audiences. The company’s solutions, business processes, technology platforms and design theories will lend themselves to application opportunities on a global scale.

History & Management

Jerrick was founded in 2012. Initially a private media company providing online content through a portfolio of brands, Jerrick’s needs quickly outpaced its initial technology and product offering. In 2015, Jerrick partnered with Thinkmill, a premiere, Australia-based product design and development group to create a content management system (CMS) for its brands; that system evolved into the company’s flagship product, Vocal.

Today, Jerrick’s management team is an impressive group of abstract thinkers united by their passion to solve problems. Leading the team are founder and CEO Jeremy Frommer, and Justin Maury, Jerrick’s president and head of product.

Frommer’s career includes two decades in the financial technology industry, working as a hedge fund and portfolio manager, as well as on the sell-side of the financial industry. Frommer started NextGen Trading, a software development company building proprietary equity trading platforms. NextGen was acquired by Carlin Financial Group of which Frommer became CEO. RBC Capital Markets Corporation eventually bought Carlin. At RBC, Frommer was managing director, head of the Global Prime Services group and a member of the RBC Global Equities Operating Committee.

Maury joined Jerrick in 2013, bringing with him 10 years of experience in the creative industry. Since partnering with Frommer to establish Jerrick, Maury led the company’s product development for more than four years. His passion for the creative arts and technology ultimately yielded the vision for Vocal. During the Jerrick’s early formative years, Maury was a driving force in creating the vision, design and architecture for the Vocal platform and managing the oversight of technology development.

Jerrick Media Holdings, Inc. (JMDA), closed Thursday's trading session at $4.00, even for the day, on 2,000 volume. The average volume for the last 3 months is 1,398 and the stock's 52-week low/high is $1.63999998/$5.00.

Recent News

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com (OTCQB: CIIX) CEO Warren Wang recently discussed the company’s growth potential and the vital role of its CBD Biotech subsidiary during an interview on MoneyTV with Donald Baillargeon (http://cnw.fm/6imjU). Also today, the company was featured in the 420 with CNW by CannabisNewsWire. Marijuana customers in Illinois are in for a price shock come July 1 this year as new taxes take effect. Currently, in Illinois, marijuana sales are being subjected to state and local taxes, plus an additional state marijuana excise tax, which has increased the overall tax rate from 20.25% to 35.25% in the municipalities and counties. This also depends on the potency of marijuana being sold.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Thursday's trading session at $0.175, even for the day, on 55,026 volume with 9 trades. The average volume for the last 3 months is 53,345 and the stock's 52-week low/high is $0.150000005/$0.550000011.

Recent News

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Mr. Corey Lambrecht is a 20-year public company executive and rejoins SinglePoint (OTCQB: SING) as their new CFO as SinglePoint focuses near term strategic efforts on expansion of the revenues and national footprint of its most recent acquisition, Direct Solar of America.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Thursday's trading session at $0.009, even for the day, on 1,800,557 volume with 72 trades. The average volume for the last 3 months is 3,347,747 and the stock's 52-week low/high is $0.007/$0.023499999.

Recent News

Sigma Labs Inc. (NASDAQ: SGLB)

The QualityStocks Daily Newsletter would like to spotlight Sigma Labs Inc. (SGLB).

As additive manufacturing – or 3D metal printing – gains traction in the manufacturing world, the problems with the technology have hampered production and stymied large-scale uptake. Sigma Labs Inc. (NASDAQ: SGLB), a leading producer of quality-assurance software for the commercial 3D-printing industry, is committed to providing answers to those problems in the latest version of its proprietary technology. Also today, NetworkNewsWire released a report on the company detailing how SGLB is set to assist aerospace manufacturers in beating their 3D quality manufacturing concerns. To view the full article, visit http://nnw.fm/8uCEs

Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.

For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.

Revolutionizing Additive Manufacturing

Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.

Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.

Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.

The Challenge

Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.

Innovative Approach

Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.

Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.

Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.

Market Opportunity

Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.

Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.

Management Team

John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.

Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.

CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.

Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.

Sigma Labs Inc. (SGLB), closed Thursday's trading session at $0.928, off by 0.215054%, on 21,321 volume with 87 trades. The average volume for the last 3 months is 197,045 and the stock's 52-week low/high is $0.451099991/$2.45000004.

Recent News

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF)

The QualityStocks Daily Newsletter would like to spotlight HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF).

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) was featured today in a publication from HempWireNews, examining how, for years, China has been the primary source of hemp imports into the United States. However, on Wednesday, China entered into a new trade agreement with the U.S. which requires it to buy more of the non-psychoactive marijuana crop from the U.S.

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.

Advanced Extraction Technologies

For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:

  • LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
  • PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
  • Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.

Delta Purification® Technology

HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:

  • Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
  • Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
  • Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.

Hemp Biomass and Tolling Contracts

HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.

Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.

re3™ Technology

Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.

The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.

Sales and Offtake Agreements

HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.

Project Construction

HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.

Leadership

Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.

Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.

HTC Extraction Systems (OTCQB: HTPRF), closed Thursday's trading session at $0.1852, off by 16.3807%, on 150 volume with 2 trades. The average volume for the last 3 months is 2,838 and the stock's 52-week low/high is $0.100299999/$0.920000016.

Recent News

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global Corporation (OTCQB: SHRG), a diversified holdings company, reported sales of $38,850,483 for Q2 2019 in the 10-Q it recently filed with the SEC for the three months ended October 31, 2019 (http://nnw.fm/qV6ke). To view the full article, visit http://nnw.fm/b5fBy

Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.

Proprietary Products

SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.

The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.

Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.

Global Network of Elepreneurs

Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.

SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”

Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.

In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.

Continued Momentum as Industry Leader

These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.

SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.

These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.

These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.

Preparing for Success

SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.

Contact
469.304.9400 x 201
Info@SHRGinc.com
http://www.SHRGinc.com

Sharing Services Global Corporation (SHRG), closed Thursday's trading session at $0.095, off by 10.3774%, on 10,200 volume with 2 trades. The average volume for the last 3 months is 41,099 and the stock's 52-week low/high is $0.065800003/$0.3944.

Recent News

No Borders Inc. (OTC: NBDR)

The QualityStocks Daily Newsletter would like to spotlight No Borders Inc. (NBDR).

Trust and wellness provider No Borders Inc. (OTC: NBDR)inspires confidence through its diverse approach to market building, living up to its name by extending its reach to a variety of explosive growth verticals. Two of those sectors are hemp-based cannabis products and blockchain security applications, which can work together to symbiotically help consumers improve their general well-being. Also today, CryptoCurrencyWire released a report on the company detailing how NBDR has subsidiaries that are actively targeting rapidly growing markets, including blockchain technology and hemp. To view the full article, visit http://ccw.fm/t51E0

No Borders Inc. (OTCQB: NBDR) specializes in the acquisition, creation and scaling of commercial products by utilizing cutting-edge technologies designed to reduce costs while increasing revenues and shareholder value. With active subsidiaries in healthcare, education, cannabidiol (CBD), finance and technology, No Borders is uniquely positioned to use its expertise to improve margins and add business lines within target verticals. No Borders is headquartered in Arizona with remote work resources in the U.S., South America, Asia and Europe.

Different by Design

Deeply experienced at actionable data compilation, analysis and utilization, No Borders believes that data utilization in a Web 3 ecosystem of predictive analytics, blockchains, consensus algorithms, IoT and 5G are vital keys to the future of disrupting global business.

The company leverages its technological talent and visionary approach alongside best-in-class branding, messaging and product teams to simultaneously deploy multiple vertical product offerings at the same time.

With resources around the world, No Borders operates as a 100% remote work, lean operating organization with a founding ideological focus on “Lifestyle by Design.” No Borders’ teams are built by allowing people to work when they want and from where they want as long as deliverables and results are achieved. This structure allows for strategic talent acquisition without the need for relocation or commuting; lowered operating and fixed costs; as well as improved morale and substantially increased staff productivity.

NBDR Companies

  • No Borders Dental Resources Inc. provides equipment and supplies to medical and dental professionals across the U.S. through the trade name, MediDent Supplies. MediDent has a strategic focus on expanding product portfolios and optimizing lifetime customer value while minimizing customer acquisition cost in the medical, dental and veterinary spaces.
  • No Borders Naturals is a purveyor of health and wellness products for active consumers and their pets. No Borders Naturals aims to be an industry leader in alternative wellness product offerings and is currently expanding its digital offering with impactful product up-sell opportunities such as a series of “Buy Two-Get One” on products on its 1000mg CBD tincture, collagen and retinol beauty cream.
  • No Borders Labs Inc. provides leading-edge tech tools to the No Borders family of companies along with building, testing and deploying technology solutions and products to the market while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security and transparency.
  • No Borders Funding Inc. provides internal capital and strategic funding options for the family of No Borders companies while actively engaging and networking to find, acquire, structure and deploy unique financial products, solutions and systems with traditional, distributed ledger and blockchain technologies.
  • No Borders Education Inc. provides internal staff training and strategic education tools for the No Borders family of companies while pursuing external revenue generating educational opportunities within the verticals for which No Borders deploys products, services or technologies.

 

Leadership

No Borders CEO Joseph Snyder is a serial entrepreneur whose experiences in real estate investment, financial services and digital strategy over the last 15 years provide a strong, grounded foundation for the structure and ideas outlined in the company’s strategic plan. He brings a unique set of long-term business experiences that provide No Borders with a clear “mile-high” view of the intricately linked systems and challenges associated with growing and scaling our vision.

COO Cynthia Tanabe, a licensed real estate agent/broker since 2004, has successfully built a highly respected investor and bank-focused real estate and property management firm in Arizona with tens of millions of dollars of properties owned and sold.

CTO Chris Brown has 14 years of experience in the IT industry ranging from full stack programming, hardware support, engineering and maintenance, to enterprise-level information system analysis, design, development and implementation. From his background in Air Force intelligence to earning dual B.S. degrees in computational mathematics and biochemistry from Arizona State University, Brown has been engrossed with technologies such as artificial intelligence, machine learning, and decentralized blockchain ledger systems and their connections with real world business applications.

Management is backed by an advisory board with a diverse range of expertise blockchain, brand development, specialty retail, branded consumer products, technology, marketing and other specialties pertinent to No Borders’ growth strategy.

No Borders Inc. (NBDR), closed Thursday's trading session at $0.012812, off by 8.4857%, on 164,057 volume with 5 trades. The average volume for the last 3 months is 100,894 and the stock's 52-week low/high is $0.007699999/$0.048799999.

Recent News

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

CFN Media (OTCQB: CNFN), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing The Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) and the companies simple approach.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees and culture of innovation. The company aims to grow the world’s best legal cannabis and become a leader in the global industry. Supreme Cannabis calls its Toronto Venture Exchange stock symbol, “FIRE,” a testament to the company’s passion for cannabis and obsession with quality.

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as one of Canada’s most premium cannabis producers, the company sees itself at the center of this global shift.

A key piece of Supreme Cannabis’ ability to fulfill its mission is its flagship brand, 7ACRES, a wholly owned subsidiary that operates a 440,000-square-foot hybrid cultivation facility in Kincardine, Ontario. 7ACRES is focused on building a core competency in scaled high-quality cannabis production. With a best-in-class cultivation facility producing a competitive product that fuels a leading premium brand, Supreme Cannabis has achieved a differentiated advantage in cultivation IP, products and branding. The company’s foundational investment in premium cultivation has secured it a leadership position in the industry as the Canadian market becomes more competitive and matures.

Since legalization, 7ACRES has brought five premium flower strains to market in Canada. The demand for 7ACRES product continues with the company’s most recent launch of Jack Haze, a new proprietary premium cultivar. The company’s first sativa-dominant strain, Jack Haze offers rare sensory characteristics, delivering high THC content with a terpinolene forward profile, including a complex aroma with notes of citrus, pine and warm spice. As it develops its next winning strain, 7ACRES continues to prioritize subjective quality. In the Canadian cannabis market, this approach has established 7ACRES as a well-known premium brand that commands premium pricing coast-to-coast.

In addition to 7ACRES, Supreme Cannabis has built a diversified portfolio of focused consumer-driven brands:

  • Sugarleaf by 7AC – this new brand widens Supreme Cannabis’ product offerings and targets consumers who are looking for more refined, milder consumption experience as they discover their own cannabis taste preferences and desires. Product formats under this brand are focused on offering consumers elegant and convenient cannabis experiences.
  • Blissco — dedicated to providing wellness focused consumers with premium cannabis products, education, and outstanding customer care. Blissco is focused on bringing its collection of premium whole-flower CBD oils to market.
  • Truverra — focused on being a global leader in the development, production and marketing of hemp and cannabis-derived medicinal products with clinically proven efficacy. With over 25 SKUs sold online in the UK and Europe, Truverra is ideally positioned to address emerging international cannabis opportunities.
  • Khalifa Kush Enterprises — formed through a prestigious international partnership with Khalifa Kush Enterprises (KKE) Canada, the Canadian counterpart to the popular U.S. cannabis brand KKE formed by Wiz Khalifa. Together, Supreme Cannabis and KKE Canada are developing and launching a lineup of premium cannabis products, including a future line based on the well-known Khalifa Kush strain.

Each of Supreme Cannabs’ brands and partnerships have been strategically identified and designed to support the company’s mission to enhance the lives of consumers through positive cannabis experiences. Equally important to delivering desirable consumer experiences is the infrastructure supporting the company’s brands and products. From seed to sale, supreme cannabis continues to build an impressive group of operating assets that serve key functions throughout the value chain:

  • Cultivation – for starters, there is Supreme Cannabis’ foundational flagship asset, its 440,000-square-foot cultivation facility in Kincardine, Ontario. With over 600 employees, 24 grow rooms, and best-in-class processing equipment and procedures, this facility is expected to reach an annual production capacity of 50,000 kilograms in the near-term. In this purpose-built facility, the company grows small-batch high-quality cannabis from 10,000-square-foot grow rooms and completes a proprietary hang-dry for up to two weeks.
  • Extraction – with the acquisition of Blissco in fiscal 2019, in addition to the Blissco wellness brand, Supreme Cannabis gained a 12,000-square-foot dedicated extraction facility in Langley, BC. This facility conducts both C02 and ethanol extraction and with the recent receipt of its oil sales license from Health Canada, it now produces Blissco branded CBD oils and expects to fill vaporizer pods for a partnership between the company’s 7ACRES brand and Pax Labs.
  • Manufacturing – most recently, the company announced its 107,000-square-foot processing, packaging and manufacturing facility in Kitchener, naming the facility Supreme Cannabis Kitchener. In Q4 FY2020, the company expects to begin whole flower packaging and pre-roll manufacturing for Supreme Cannabis brands at the Kitchener Facility. In the long-term, in additional to processing its own inputs, Supreme Cannabis intends generate incremental revenue by packaging, distributing and branding third-party cannabis inputs from quality-focused cultivators.
  • R&D and Product Testing – In Q1 FY2020, Supreme Cannabis closed the acquisition of Truverra and acquired a 5,000-square-foot facility licensed under Canadian Clinical Cannabinoids Inc. in Scarborough, Ontario (“Supreme Cannabis Scarborough”). Supreme Cannabis Scarborough provides R&D space for the company to test new products and develop medicinal science intellectual property. In the near-term, with the legalization of 2.0 cannabis products, this centre for innovation will be testing and bringing concentrate products to market under the 7ACRES brand.

Supreme is committed to continue to identify new opportunities to grow and strengthen its impressive portfolio of operating assets and brands and scale its strong Canadian business globally.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Thursday's trading session at $0.4285, up 3.6025%, on 199,510 volume with 192 trades. The average volume for the last 3 months is 527,053 and the stock's 52-week low/high is $0.346799999/$1.7888.

Recent News

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF), an Ontario-based cannabis company recognized for its premium products and services, today announced that its common shares are set to start trading on the Toronto Stock Exchange (“TSX”) under the symbol ‘VIVO’ at market open on January 24, 2020. The company’s common shares will be voluntarily delisted from the TSX Venture Exchange in connection with the TSX listing. To view the full press release, visit http://cnw.fm/TFEl3

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed Thursday's trading session at $0.35054, up 15.4421%, on 595,346 volume with 295 trades. The average volume for the last 3 months is 172,474 and the stock's 52-week low/high is $0.139899998/$0.930000007.

Recent News

OriginClear (OTC: OCLN)

The QualityStocks Daily Newsletter would like to spotlight OriginClear (OTC: OCLN).

OriginClear (OTCQB: OCLN), a leading provider of water treatment solutions, today announced its entry into a strategic partnership with Permionics Separations Solutions, Inc., a unit of India’s Permionics Group (Permionics) for the Asia-Pacific Region. Permionics, based in the Indian state of Gujarat, is a leading Indian liquid separations company, specializing in water treatment. To view the full press release, visit http://nnw.fm/wy98A

OriginClear (OTC: OCLN) leads the self-reliant water revolution, deploying advanced technologies at the point of use, with modular, prefabricated systems that create durable assets and water independence for industry, commerce and agriculture.

Failing infrastructure and the rising cost of water are driving businesses to treat their own water. OriginClear leads this megatrend with on-premise systems enabling very high purification and recycling levels that centralized systems cannot achieve.

Systems installed at the point of use become productive assets for businesses that also increase property values. And OriginClear helps corporations improve their environmental, social and governance (ESG) standings with world-class water management.

Operations & Markets

OriginClear leads a new generation of water companies that focus on meeting the needs of businesses looking for compact, advanced technologies that can be shipped to and installed at the point of use. The company manufactures and distributes its professional-grade water treatment and conveyance products to commercial and industrial properties, fielding both direct and indirect sales channels to reach end-market clients such as hotels and resorts, real estate housing developments, office buildings, military installations, schools, farms, food and beverage manufacturers, industrial warehouse, oil and gas producers, and medical and pharmaceutical facilities.

From its Texas-based factory, OriginClear designs and prefabricates an entire line of plug-n-play containerized units called Modular Water Systems™ that enable water purification, recycling and wastewater management.


Industrial Pretreatment Waste Water Treatment Plant (WWTP) designed by Daniel M. Early, using reinforced thermoplastic modules.

These onsite modular products provide clients with water independence through ownership and operational control over water quality, enabling them to increase productivity while reducing environmental, health and safety risks from pollution, contamination and corrosion. Modular water products are trusted to balance performance with cost-effectiveness, enabling business users to go well beyond municipal standards for water quality, therefore achieving high levels of satisfaction for their own customers, and improved sustainability for their properties.

OriginClear’s water treatment equipment can boost real estate asset value as a fundamental capital improvement, combined with long-lasting water savings for the corporate bottom line.

Product Portfolio

OriginClear groups its products into three main categories:

  1. Water Treatment: achieving high grade purification.
  2. Water Conveyance: water transportation and pumping.
  3. Advanced Technologies: commercialization of innovative technologies.

OriginClear’s complete line of compact, on-site, point-of-use products include: advanced purification systems that are skid, rack-mounted and containerized for reverse osmosis, ultrafiltration, media filtration, disinfection, water softening, ion exchange and electrodeionization (EDI), combined as needed in small to medium commercial and industrial applications, and custom-build projects. Water conveyance products include pump and lifting stations, modular storage tanks, and control monitoring panels.

OriginClear’s line of modular water products and systems is key to the self-reliant water treatment revolution as they create “instant infrastructure” – fully engineered, prefabricated and prepackaged systems that use durable, sophisticated materials. The units are available in standard capacities for onsite closed-loop systems at commercial business locations.

The company’s rugged wastewater treatment plants, highly reliable pump stations, and premium water purification units typically offer 25 percent lower initial costs over conventional systems, with greater quality and full connectivity. These pump stations and wastewater treatment products utilize high density thermo-plastics (HDPE) and proprietary, innovative prefabrication methods and materials that deliver the longest life and strongest products.

Breakthrough Technologies

OriginClear has a long history of innovation through its OriginClear Technologies division, which is responsible for identifying leading-edge technologies to solve today’s toughest challenges. These advanced technologies are the centerpiece of the division’s international licensee network. The technologies are developed in OriginClear Technologies, and licensees integrate them into their own products.

Electro Water Separation™ (EWS) and Advanced Oxidation (AOx™) are the principal, well-proven technologies.

EWS is OriginClear’s breakthrough water cleanup technology which utilizes a catalytic process to concentrate and eliminate suspended solids in the worst commercial and industrial wastewater.

AOx is OriginClear’s proprietary advanced oxidation technology which generates a dense cloud of ozone, hydrogen peroxide and hydroxyl radicals, dramatically reducing or eliminating dissolved organic microtoxins, including bacteria and viruses, hormones, drugs, pesticides such as Roundup, and synthetics. AOx has also been shown to effectively reduce harmful chemicals such as ammonia and hydrogen sulfide – the “rotten egg” smell in crude oil that reduces its value.

Through international licensing and partnerships, OriginClear’s advanced technologies are being adopted to treat tough water problems in East and South Asia, Europe and the Middle East, and North America.

Market Opportunity

In just 10 years, the global water services market has doubled into a trillion-dollar industry, driven by improper sanitation and water scarcity. Only 20 percent of all sewage and only 30 percent of all industrial waste are ever treated. Additionally, water leakage results in the loss of 35 percent of all clean water across the planet; reducing that percentage by half would provide clean water for 100 million people. This is a situation of great danger, but also great potential.

The statistics demonstrate that we can no longer rely on the efficiencies of giant, centralized water utilities to meet these challenges. An increasing number of businesses are starting to take notice, instead conducting their own water treatment and recycling. Whether by choice or out of necessity, those businesses that do invest in onsite water systems get a tangible asset on their business and real estate, and can enjoy better water quality at a lower cost.

Out of the public’s eye and with OriginClear’s help, a growing number of self-reliant businesses are building Decentralized Water Wealth™ for themselves while also helping their community. They know that environmental, social and governance (ESG) investing guidelines, which represent $22 trillion of assets under management around the world, specifically note the key indicator of how well corporations manage their water.


10,000 Gallon per Day Industrial Membrane Bioreactor Waste Water Treatment Plant designed by Daniel M. Early, PE, using long-lived Structural Reinforced ThermoPlastic (SRTP)

OriginClear is a key enabler of ESG water management for corporations that are increasingly responsible for what was once delegated to central utilities. For example, when a corporation manages its own water, and uses OriginClear’s proprietary hybrid treatment methods, it can significantly reduce both water use and nutrient footprints (carbon, nitrogen, and phosphorus) in one compact package.

These hybrid processes feature advanced blackwater treatment with advanced clean water processing. They can convert toxic nutrients to less harmful compounds, and even capture them for beneficial reuse purposes, as shown in OriginClear’s recent case study.

Revenue Growth through Synergy

Since OriginClear acquired it in 2015, Progressive Water Treatment has generated steady revenues in the range of a million dollars a quarter. It is now the Fabrication and Manufacturing Division for the whole company. The team at Modular Water Systems, headed by Chief Engineer Daniel M. Early, is responsible for overall design and high-level engineering. It relies on the Fabrication and Manufacturing Division to add incremental revenue for its modular product line, without requiring large increases in personnel.

OriginClear believes that these two business units can develop growing revenues through synergy and ultimately help achieve overall profitability. OriginClear also seeks to acquire profitable water companies that can complement the synergy of its existing units and accelerate both revenues and profitability. However, acquisitions are neither guaranteed, nor essential to OriginClear’s continued growth.

 

Leadership

OriginClear’s management team brings strong leadership and a background in managing business operations, sales, technologies, and finance. The team combines idealism with solid commercial skills, achieving a triple bottom line of environmental, social and financial gain.

Riggs Eckelberry – Chairman, CEO and Co-founder
Riggs Eckelberry is a veteran technology manager who led companies to multiple exits during the high-tech boom of the 90s and early 2000s. Eckelberry came to the water industry from a quarter century in high technology, specializing in commercializing breakthrough technologies. During the dotcom boom, he worked on a series of tech successes, such as Quarterdeck’s CleanSweep; security software vendor Panda Software; and the sale of companies to EarthWeb, BeFree, and BellSouth. Just prior to founding what is now OriginClear, he helped drive security software company CyberDefender to an IPO on the Nasdaq as its president and chief operating officer.

Thomas Marchesello – Chief Operating Officer
Thomas Marchesello is a business operations and technology executive with over 20 years’ experience in manufacturing and distribution of products and services. He has 12 years in private equity M&A, doing buyside acquisitions of small to midsize corporations. He has over 10 years advising innovative corporations on ESG strategy and speaks often about industry trends. He began his career in the U.S. Air Force, Space Command Headquarters for environmental sciences. He has held key roles for Fortune 500 companies such as Sony, Thompson Reuters, Morgan Stanley, and Chicago Mercantile Exchange.

Daniel M. Early, PE – Senior Engineer
For the past 25 years, Dan Early has worked as an engineered products development specialist with very strong understanding of the complex and interconnected disciplines, economies, and governmental regulation needed to develop and sustain modern civil infrastructure systems that reflect a balance of environmental stewardship, social expectations, and cultural requirements. Since 2010, Early has specialized in the research, development, and deployment of next generation water infrastructure technologies using heavy plastic manufacturing. His initiatives and innovations anchor Modular Water Systems’ product line.

Marc Stevens – Director of Fabrication and Manufacturing
Marc Stevens brings nearly 40 years of experience to OriginClear’s manufacturing team. His experience in mechanical design, equipment fabrication, installation and a wide range of projects led to his founding what is now OriginClear’s Fabrication and Manufacturing Division. He supervises the design, building and installation of customized, large-scale water treatment systems, including purification technologies for process waters for boilers and cooling towers, drinking water and various industrial waste water applications. Stevens leads the team that also manufactures OriginClear’s standardized Modular Water Systems.

OriginClear (OCLN), closed Thursday's trading session at $0.1175, up 6.8182%, on 64,132 volume with 30 trades. The average volume for the last 3 months is 59,697 and the stock's 52-week low/high is $0.078749999/$5.80000019.

Recent News

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex (NASDAQ: GNPX), a clinical stage gene therapy company developing a new and potentially life-saving approach to treating some of the world’s most deadly cancers based upon a novel proprietary technology platform, today announced its entry into securities purchase agreements with institutional investors for the purchase and sale of 7,620,000 shares of common stock. To view the full press release, visit http://nnw.fm/2Mdgh.

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed Thursday's trading session at $1.4, off by 25.9259%, on 25,570,119 volume with 53,570 trades. The average volume for the last 3 months is 2,230,390 and the stock's 52-week low/high is $0.231000006/$2.25999999.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.